Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
CC transcript
Edwards Lifesciences Corp (EW) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 144 Form 144 - Report of proposed sale of securities:
07/28/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/26/2023 8-K Quarterly results
06/01/2023 144 Form 144 - Report of proposed sale of securities:
05/24/2023 144 Form 144 - Report of proposed sale of securities:
05/15/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Certificate of Amendment of Amended and Restated Certificate of Incorporation"
05/10/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 144 Form 144 - Report of proposed sale of securities:
05/05/2023 144 Form 144 - Report of proposed sale of securities:
04/28/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/26/2023 8-K Quarterly results
04/14/2023 144 Form 144 - Report of proposed sale of securities:
03/28/2023 ARS Form ARS - Annual Report to Security Holders:
03/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/14/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
02/13/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
02/13/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
02/13/2023 10-K Annual Report for the period ended December 31, 2022
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 8.3% stake in Edwards Lifesciences Corp.
02/07/2023 SC 13G/A BlackRock Inc. reports a 8.6% stake in EDWARDS LIFESCIENCES CORP
01/31/2023 8-K Quarterly results
12/08/2022 8-K Quarterly results
11/14/2022 UPLOAD Form UPLOAD - SEC-generated letter:
11/01/2022 8-K Quarterly results
10/28/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/27/2022 8-K Quarterly results
10/07/2022 144 Form 144 - Report of proposed sale of securities:
07/29/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/28/2022 8-K Quarterly results
07/21/2022 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy